PATIENT INFORMATION LEAFLET
Antin Diario 0.03 mg/3 mg film-coated tablets
Ethinylestradiol/drospirenone
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Important information about combined hormonal contraceptives (CHCs):
Antin Diario is a contraceptive and is used to prevent pregnancy.
Each yellow-colored tablet contains a small amount of two different female hormones, known as ethinyl estradiol and drospirenone.
The white-colored tablets do not contain active ingredients and are called placebo tablets.
Contraceptives that contain two hormones are called combined contraceptives.
Before starting Antin Diario, read the information about blood clots in section 2. It is particularly important that you read the symptoms of a blood clot (see section 2 “Blood Clots”).
Before starting this medication, your doctor will ask you some questions about your personal and family medical history. Your doctor will also measure your blood pressure and, depending on your health status, perform other tests.
This leaflet describes several situations in which you should interrupt the use of Antin Diario, or in which the effect of Antin Diario may be reduced.
You should not use the rhythm or temperature method. These methods may not be reliable because Antin Diario alters the monthly changes in body temperature and cervical mucus.
Antin Diario, like other hormonal contraceptives, does not protect against HIV (AIDS) or any other sexually transmitted disease.
When not to use Antin Diario
You should not use Antin Diario if you have any of the conditions listed below. Inform your doctor if you have any of the conditions listed below. Your doctor will discuss with you what other form of contraception would be more suitable.
- Severe diabetes with vascular damage.
- Very high blood pressure.
- Very high levels of fat in the blood (cholesterol or triglycerides).
- A condition called hyperhomocysteinemia.
When to have special care with Antin Diario
When to consult your doctor? Seek urgent medical assistance
For a description of the symptoms of these serious side effects, see “How to recognize a blood clot”. |
Inform your doctor if you suffer from any of the following conditions.
In some situations, you will need to take special care while using Antin Diario or any other combined hormonal contraceptive, and your doctor may need to examine you periodically. If the condition develops or worsens while you are using Antin Diario, you must also inform your doctor.
BLOOD CLOTS
The use of a combined hormonal contraceptive like Antin Diario increases your risk of suffering a blood clot compared to not using it. In rare cases, a blood clot can block blood vessels and cause serious problems.
Blood clots can form:
The recovery of blood clots is not always complete. In rare cases, there may be long-lasting effects, or very rarely, they may be fatal.
It is essential to remember that the global risk of a harmful blood clot due to Antin Diario is small.
HOW TO RECOGNIZE A BLOOD CLOT
Seek urgent medical assistanceif you notice any of the following signs or symptoms.
Do you experience any of these signs? | What could you be suffering from? |
• Swelling of a leg or foot or along a vein in the leg or foot, especially when accompanied by: • Pain or tenderness in the leg, which may only be noticeable when standing up or walking. • Increased temperature in the affected leg. • Change in skin color of the leg, e.g. if it becomes pale, red, or blue. | Deep vein thrombosis |
• Sudden shortness of breath without a known cause or rapid breathing. • Sudden coughing without a clear cause, which may bring up blood. • Sudden chest pain that may worsen with deep breathing. • Intense dizziness or fainting. • Rapid or irregular heartbeat. • Severe stomach pain. If you are unsure, consult a doctor, as some of these symptoms, such as coughing or shortness of breath, can be confused with a milder condition like a common cold. | Pulmonary embolism |
Symptoms that occur more frequently in one eye: • Sudden loss of vision, or • Blurred vision without pain, which may progress to loss of vision. | Retinal vein thrombosis (blood clot in the eye). |
• Chest pain, discomfort, pressure, or heaviness. • Feeling of oppression or fullness in the chest, arm, or under the sternum. • Feeling of fullness, indigestion, or choking. • Upper body discomfort that radiates to the back, jaw, throat, arm, or stomach. • Sweating, nausea, vomiting, or dizziness. • Extreme weakness, anxiety, or shortness of breath. • Rapid or irregular heartbeat. | Heart attack. |
• Sudden weakness or numbness in one side of the face, arm, or leg, especially in one part of the body. • Sudden confusion, difficulty speaking, or understanding. • Sudden difficulty seeing in one eye or both eyes. • Sudden difficulty walking, dizziness, loss of balance, or coordination. • Sudden severe headache, intense or prolonged without a known cause. • Sudden loss of consciousness or fainting, with or without convulsions. Sometimes the symptoms of a stroke may be brief, with almost immediate and complete recovery, but you should still seek medical attention as you may be at risk of another stroke. | Stroke |
• Swelling and slight bluish discoloration of an extremity. • Severe stomach pain (abdominal pain). | Blood clots that block other blood vessels. |
BLOOD CLOTS IN A VEIN
What can happen if a blood clot forms in a vein?
When is the risk of a blood clot in a vein higher?
The risk of a blood clot in a vein is higher during the first year in which you take a combined hormonal contraceptive for the first time. The risk may be higher if you restart taking a combined hormonal contraceptive (the same medication or a different medication) after a break of 4 weeks or more.
After the first year, the risk decreases, but it is always slightly higher than if you were not taking a combined hormonal contraceptive.
When you stop taking Antin Diario, your risk of a blood clot returns to normal in a few weeks.
What is the risk of a blood clot?
The risk depends on your natural risk of VTE and the type of combined hormonal contraceptive you are taking.
The global risk of a blood clot in the leg or lung (DVT or PE) with Antin Diario is small.
Risk of developing a blood clot in a year | |
Women whodo not usea combined hormonal contraceptive and who are not pregnant | About 2 out of every 10,000 women |
Women who use a combined hormonal contraceptive containinglevonorgestrel, noretisterone, or norgestimato | About 5-7 out of every 10,000 women |
Women who useAntin Diario | About 9-12 out of every 10,000 women |
Factors that increase your risk of a blood clot in a vein
The risk of a blood clot with Antin Diario is small, but some conditions increase the risk:
The risk of a blood clot in a vein increases the more conditions you have.
Long flights (more than 4 hours) may temporarily increase the risk of a blood clot, especially if you have any of the other risk factors listed.
It is essential to inform your doctor if you have any of the conditions above, even if you are unsure. Your doctor may decide that you should interrupt the use of Antin Diario.
If any of the conditions above change while you are using Antin Diario, for example, a close relative experiences a blood clot without a known cause, or you gain a lot of weight, inform your doctor.
BLOOD CLOTS IN AN ARTERY
What can happen if a blood clot forms in an artery?
Like a blood clot in a vein, a blood clot in an artery can cause serious problems. For example, it can cause a heart attack or a stroke.
Factors that increase your risk of a blood clot in an artery
It is essential to note that the risk of a heart attack or stroke due to Antin Diario is very small, but it may increase:
If you have one or more of these conditions or if any of them are particularly severe, the risk of a blood clot may be increased even further.
If any of the conditions above change while you are using Antin Diario, for example, you start smoking, a close relative experiences a blood clot without a known cause, or you gain a lot of weight, inform your doctor.
Antin Diario and cancer
Women who use hormonal contraceptives like Antin Diario have a slightly higher rate of breast cancer, but it is not known whether this is due to the treatment. For example, it may be that more tumors are detected in women taking hormonal contraceptives because they are examined by their doctor more frequently. The incidence of breast tumors decreases gradually after stopping hormonal contraceptives.
It is essential to undergo regular breast examinations, and you should consult your doctor if you notice any lump.
In rare cases, benign tumors in the liver have been reported in users of hormonal contraceptives, and even more rarely, malignant tumors. You should consult your doctor if you experience sudden severe abdominal pain.
Cancer of the ovaries occurs less frequently than breast cancer. The use of hormone replacement therapy (HRT) with estrogen alone or with a combination of estrogen-progestogen has been associated with a slightly higher risk of ovarian cancer.
The risk of ovarian cancer varies with age. For example, in women aged 50-54 who are not taking HRT, about 2 cases of ovarian cancer have been observed per 2,000 women over a 5-year period. In women taking HRT for 5 years, about 3 cases have been observed per 2,000 patients (i.e., about 1 additional case).
Antin Diario and psychiatric disorders
Some women who use hormonal contraceptives like Antin Diario have reported depression or a depressed mood. Depression can be severe and sometimes may induce suicidal thoughts. If you experience mood changes and depressive symptoms, contact your doctor for additional medical advice as soon as possible.
Use of Antin Diario with other medications
Always inform your doctor who prescribed Antin Diario about any medications or herbal preparations you are taking. You should also inform any other doctor or dentist who prescribes another medication (or your pharmacist) that you are taking Antin Diario. They may advise you to take additional contraceptive precautions (e.g., condoms) and, if so, for how long.
Do not take Antin Diario if you have hepatitis C and are taking medications that contain ombitasvir / paritaprevir / ritonavir and dasabuvir, glecaprevir/pibrentasvir, or sofosbuvir/velpatasvir/voxilaprevir. This may cause increases in liver enzyme test results (elevated ALT levels).
Your doctor will prescribe another type of contraceptive before starting treatment with these medications.
Antin Diario can be restarted approximately 2 weeks after the completion of this treatment. See the section “When not to use Antin Diario”.
Consult your doctor or pharmacist or nurse before starting Antin Diario.
Inform your doctor or pharmacist if you are taking or have recently taken other medications, even those obtained without a prescription.
Use of Antin Diario with food and drinks
Take one Antin Diario tablet every day with a glass of water if necessary. You can take the tablets with or without food, but every day approximately at the same time.
Laboratory tests
If you need a blood test, inform your doctor or the laboratory staff that you are taking a contraceptive, as hormonal contraceptives may affect the results of some tests.
Pregnancy and breastfeeding
Pregnancy
If you are pregnant, you should not take Antin Diario. If you become pregnant while taking Antin Diario, stop taking the medication immediately and consult your doctor.
Consult your doctor or pharmacist before using any medication.
Breastfeeding
In general, it is not recommended to take Antin Diario during the breastfeeding period. If you want to take the contraceptive while breastfeeding, you should consult your doctor.
Consult your doctor or pharmacist before using any medication.
Driving and operating machinery
There is no information to suggest that the use of Antin Diario has any effect on your ability to drive or operate machinery.
Important information about some of the components of Antin Diario
Antin Diario contains lactose. If your doctor has told you that you have a lactose intolerance, consult them before taking this medication.
If you were taking another contraceptive before starting Antin Diario, you will know that most contraceptives contain 21 tablets. With those contraceptives, you take a tablet for 21 days and then there is a week-long break during which you take none (withdrawal period without tablets).
The procedure to follow when taking Antin Diario is different. After the 21 yellow tablets, you must continue taking the 7 placebo tablets; therefore, there is no withdrawal period without tablets, but a week of "placebo" (the week in which you take the placebo tablets from row 4). Since you must take a tablet every day and there is no withdrawal period without tablets between two packs, taking them becomes a routine, and therefore the risk of forgetting a tablet is lower.
The two different colored tablets of Antin Diario are placed in order. A pack contains 28 tablets.
Take one Antin Diario tablet every day with a glass of water if necessary. You can take the tablets with or without food, but every day approximately at the same time.
Do not confuse the tablets: take a yellow tablet for the first 21 days, and then a white tablet for the last 7 days. You must then start taking a new pack (21 yellow tablets and 7 white tablets). Therefore, there is no withdrawal period without tablets between packs.
Due to the different composition of the tablets, you must start with the first tablet located in the top left corner and then take a tablet every day. To maintain the order, follow the direction of the arrows on the pack.
Preparation of the pack
To keep track of daily Antin Diario tablet intake, each pack (blister) of Antin Diario includes seven adhesive strips with the days of the week printed on them. You must know the day of the week on which you will take the first tablet.
According to the day of the week on which you will start taking the tablets, you should choose the corresponding strip, for example, if you start on Wednesday, stick the one that says "WED" as the initial tablet.
Then, you must stick the corresponding strip on the top left of the pack, in the "Start" position. In this way, there is a day of the week indicated above each tablet, and you can visually check if you have taken a particular tablet. The arrows show the order in which the tablets should be taken.
During the 7 days in which you take placebo tablets (placebo week), menstruation (also called withdrawal bleeding) usually begins. Normally, menstruation begins the second or third day after taking the last active tablet, yellow-colored etinilestradiol/drospirenona. Once you have taken the last white tablet, you must start a new pack, even if the bleeding has not finished. This means that you should start the new pack on the same day of the week as the previous one, and that menstruation should occur on the same days every month.
If you take Antin Diario as indicated, you will also be protected against pregnancy during the 7 days in which you are taking placebo tablets.
When can you start with the first pack?
Start taking Antin Diario on the first day of the cycle (i.e., the first day of your menstruation). If you start Antin Diario on the first day of your menstruation, you will be immediately protected against pregnancy. You can also start on days 2-5 of the cycle, but you must use additional contraceptive methods (e.g., a condom) during the first 7 days.
You can start taking Antin Diario the day after the withdrawal period of your previous contraceptive (or after taking the last inactive tablet). When switching from a vaginal combined contraceptive ring or patch, follow your doctor's recommendations.
You can switch from the progestin-only pill on any day (if it is an implant or IUD, on the day of its removal; if it is an injectable, on the day of the next injection), but in all cases, it is recommended that you use additional contraceptive methods (e.g., a condom) during the first 7 days of taking tablets.
Follow your doctor's recommendations.
After giving birth, you can start taking Antin Diario between 21 and 28 days. If you start later, you must use one of the so-called barrier methods (e.g., a condom) during the first 7 days of Antin Diario use.
If, after giving birth, you have had sex again before starting Antin Diario (again), you must first be sure you are not pregnant or wait for your next menstrual period.
Let your doctor advise you if you are unsure when to start.
Read the "Breastfeeding" section.
What to do if you take more Antin Diario than you should
No serious cases of overdose of etinilestradiol/drospirenona have been reported.
The symptoms that may appear if you take many tablets at once are nausea and vomiting. Adolescent women may experience vaginal bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service 91 562 04 20 indicating the medication and the amount ingested.
What to do if you forget to take Antin Diario
The tablets in thefourthrow of the pack are placebo tablets. If you forget to take one of these tablets, the effect of Antin Diario will not be affected. You should discard the forgotten placebo tablet to avoid prolonging the placebo week, which could have a negative effect on the efficacy of Antin Diario tablets.
If you forget to take a tablet from the1st, 2nd, or 3rdrow, follow these recommendations:
The risk of incomplete protection against pregnancy is maximum if you forget to take the tablet at the beginning of the pack (1st row) or at the end of week 3 (3arow of the pack). Therefore, you should take the following measures (see the diagram below):
Consult your doctor.
Take the forgotten tablet as soon as you remember, even if this means taking two tablets at once. Continue taking the subsequent tablets at the usual time and useadditional precautions, such as a condom, for the next 7 days. If you have had sex in the week before forgetting the tablet, you should know that there is a risk of pregnancy. In that case, consult your doctor.
Take the forgotten tablet as soon as you remember, even if this means taking two tablets at once. Continue taking the subsequent tablets at the usual time. The contraceptive protection is not reduced, and you do not need to take additional precautions.
You can choose between two options:
Probably, you will have menstruation (withdrawal bleeding) at the end of the second pack, during the placebo tablet intake, although you may experience spotting or bleeding during the second pack intake.
If you follow one of these two recommendations, you will remain protected against pregnancy.
What to do in case of vomiting or intense diarrhea
If you have vomiting in the 3-4 hours following the intake of an active yellow tablet or experience intense diarrhea, there is a risk that the active principles will not be fully absorbed by the body. This is similar to what happens when you forget a tablet. After vomiting or diarrhea, you should take a tablet from a reserve pack as soon as possible. If possible, take it before 12 hours have passed since the usual time you take your contraceptive. If not possible or more than 12 hours have passed, follow the advice in the "If you forget to take Antin Diario" section.
Spotting between menstrual periods
During the first months of Antin Diario use, unexpected bleeding (bleeding outside the placebo period) may appear. If you experience these bleedings for more than a month, or if they start after a month, you must have your doctor investigate the cause.
What to do if you do not have your period during the placebo phase
If you have taken all the yellow tablets correctly, have not vomited, have not experienced intense diarrhea, and have not taken any other medication, it is very unlikely that you are pregnant.
If you do not have two consecutive menstrual periods, you may be pregnant. In this case, go to your doctor immediately. Do not start the next pack until you are sure you are not pregnant.
Delaying menstruation: what you should know
Although not recommended, it is possible to delay your menstrual period (withdrawal bleeding) until the end of a new pack if you do not take the white placebo tablets from the fourth row and start taking a second pack of Antin Diario. You may experience spotting (drops or spots of blood) or bleeding during the use of the second pack. After the usual placebo week in which you take the 7 white tablets, start the next pack.
You should consult your doctor before deciding to delay your menstrual period.
Changing the first day of your menstrual period: what you should know
If you take the tablets as instructed, your menstrual period (withdrawal bleeding) will begin during the placebo period. If you need to change that day, you can do so by shortening (but never lengthening) the placebo period. For example, if your placebo period begins on Friday and you want to change it to Tuesday (3 days earlier), you must start a new pack 3 days earlier than usual. If you shorten the placebo period too much (e.g., 3 days or less), you may not experience withdrawal bleeding during this period. Then you may experience spotting (drops or spots of blood) or bleeding.
If you are unsure how to proceed, consult your doctor.
Stopping treatment with Antin Diario
You can stop taking Antin Diario whenever you want. If you do not want to get pregnant, consult your doctor about other effective birth control methods.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. If you experience any side effect, especially if it is severe and persistent, or if you have any health changes that you think may be due to Antin Diario, consult your doctor.
All women taking combined hormonal contraceptives are at a higher risk of developing blood clots in the veins (venous thromboembolism (VTE)) or blood clots in the arteries (arterial thromboembolism (ATE)). For more detailed information on the different risks of taking combined hormonal contraceptives, see section 2 “What you need to know before starting to take Antin Diario”.
The following list of side effects has been associated with the use of Etinilestradiol/drospirenona 0.03 mg/3 mg.
The chances of having a blood clot may be higher if you have any other condition that increases this risk (see section 2 for more information on conditions that increase the risk of blood clots and symptoms of a blood clot).
Reporting side effects:
If you experience any type of side effect, consult your doctor, pharmacist or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use:http://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions.
Do not use this medication after the expiration date that appears on the packaging after “CAD”: The expiration date is the last day of the month indicated.
Do not dispose of medications through drains or trash. Dispose of packaging and unused medications at your local SIGRE collection point at your usual pharmacy. Ask your pharmacist how to dispose of packaging and unused medications. By doing so, you will help protect the environment.
Composition of Antin Diario:
Active tablets:
The active principles are 0.03 mg of ethinylestradiol and 3 mg of drospirenone.
The other components are:
Tablet core: lactose monohydrate, cornstarch, pregelatinized cornstarch, crospovidone, povidone, polisorbate 80 (E433), magnesium stearate.
Coating: partially hydrolyzed polyvinyl alcohol, titanium dioxide (E-171), macrogol 3350 (E1521), talc (E553b) and yellow iron oxide (E-172).
Placebo tablets:
Tablet core: anhydrous lactose, povidone, magnesium stearate.
Coating: partially hydrolyzed polyvinyl alcohol, titanium dioxide (E-171), macrogol 3350, talc.
Appearance of the product and content of the container
The active tablets are film-coated, round, yellow tablets.
The placebo tablets are film-coated, round, white tablets.
Antin Diario is available in boxes of 1 and 3 containers (blister packs), each containing 28 tablets (21 active tablets plus 7 placebo tablets).
Marketing authorization holder
Kern Pharma, S.L.
Venus, 72 - Pol. Ind.Colón II
08228 Terrassa - Barcelona
Spain
Responsible for manufacturing
Laboratorios León Farma, S.A.
Pol. Ind. Navatejera
C/ La Vallina s/n
24193 - Villaquilambre, León
Spain
Last review date of this leaflet: November 2022
“Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) athttp://www.aemps.gob.es/”
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.